moxifloxacin Ophthalmic Solution [Vigamox]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BackgroundDry eye disease (DED) is a prevalent complication of diabetes and presents as reduced tear production and/or increased… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
In addition to the breadth of activity of antibacterial medications as well as to their pharmacokinetic and pharmacodynamic… (More)
Is this relevant?
2017
2017
The objective of this research was to develop and evaluate an ocular insert for the controlled drug delivery of moxifloxacin… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
In addition to the spectrum of antibacterial activity of antimicrobial medicines and their pharmacokinetic and pharmacodynamic… (More)
Is this relevant?
2009
2009
ZusammenfassungHintergrundDie Wirksamkeit von Moxifloxacin (Vigamox®) umfasst die meisten für bakterielle Endophthalmitiden… (More)
Is this relevant?